BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 29048420)

  • 1. Characterization of pulmonary arteriovenous malformations in ACVRL1 versus ENG mutation carriers in hereditary hemorrhagic telangiectasia.
    Mu W; Cordner ZA; Yuqi Wang K; Reed K; Robinson G; Mitchell S; Lin D
    Genet Med; 2018 Jun; 20(6):639-644. PubMed ID: 29048420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutations in the ENG, ACVRL1, and SMAD4 genes and clinical manifestations of hereditary haemorrhagic telangiectasia: experience from the Center for Osler's Disease, Uppsala University Hospital.
    Karlsson T; Cherif H
    Ups J Med Sci; 2018 Sep; 123(3):153-157. PubMed ID: 30251589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and molecular characterization of patients with hereditary hemorrhagic telangiectasia: Experience from an HHT Center of Excellence.
    Latif MA; Sobreira NLD; Guthrie KS; Motaghi M; Robinson GM; Shafaat O; Gong AJ; Weiss CR
    Am J Med Genet A; 2021 Jul; 185(7):1981-1990. PubMed ID: 33768677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The ACVRL1 c.314-35A>G polymorphism is associated with organ vascular malformations in hereditary hemorrhagic telangiectasia patients with ENG mutations, but not in patients with ACVRL1 mutations.
    Pawlikowska L; Nelson J; Guo DE; McCulloch CE; Lawton MT; Young WL; Kim H; Faughnan ME;
    Am J Med Genet A; 2015 Jun; 167(6):1262-7. PubMed ID: 25847705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hereditary hemorrhagic telangiectasia: clinical features in ENG and ALK1 mutation carriers.
    Sabbà C; Pasculli G; Lenato GM; Suppressa P; Lastella P; Memeo M; Dicuonzo F; Guant G
    J Thromb Haemost; 2007 Jun; 5(6):1149-57. PubMed ID: 17388964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutation analysis in hereditary haemorrhagic telangiectasia in Germany reveals 11 novel ENG and 12 novel ACVRL1/ALK1 mutations.
    Wehner LE; Folz BJ; Argyriou L; Twelkemeyer S; Teske U; Geisthoff UW; Werner JA; Engel W; Nayernia K
    Clin Genet; 2006 Mar; 69(3):239-45. PubMed ID: 16542389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Somatic Mutations in Vascular Malformations of Hereditary Hemorrhagic Telangiectasia Result in Bi-allelic Loss of ENG or ACVRL1.
    Snellings DA; Gallione CJ; Clark DS; Vozoris NT; Faughnan ME; Marchuk DA
    Am J Hum Genet; 2019 Nov; 105(5):894-906. PubMed ID: 31630786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hereditary hemorrhagic telangiectasia associated with cortical development malformation due to a start loss mutation in ENG.
    Villa D; Cinnante C; Valcamonica G; Manenti G; Lanfranconi S; Colombi A; Ghione I; Saetti MC; D'Amico M; Bonato S; Bresolin N; Comi GP; Ronchi D
    BMC Neurol; 2020 Aug; 20(1):316. PubMed ID: 32847536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical features and mutations in the ENG, ACVRL1, and SMAD4 genes in Korean patients with hereditary hemorrhagic telangiectasia.
    Lee ST; Kim JA; Jang SY; Kim DK; Do YS; Suh GY; Kim JW; Ki CS
    J Korean Med Sci; 2009 Feb; 24(1):69-76. PubMed ID: 19270816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutation affecting the proximal promoter of Endoglin as the origin of hereditary hemorrhagic telangiectasia type 1.
    Albiñana V; Zafra MP; Colau J; Zarrabeitia R; Recio-Poveda L; Olavarrieta L; Pérez-Pérez J; Botella LM
    BMC Med Genet; 2017 Feb; 18(1):20. PubMed ID: 28231770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and validation of a novel pathogenic variant in GDF2 (BMP9) responsible for hereditary hemorrhagic telangiectasia and pulmonary arteriovenous malformations.
    Balachandar S; Graves TJ; Shimonty A; Kerr K; Kilner J; Xiao S; Slade R; Sroya M; Alikian M; Curetean E; Thomas E; McConnell VPM; McKee S; Boardman-Pretty F; Devereau A; Fowler TA; Caulfield MJ; Alton EW; Ferguson T; Redhead J; McKnight AJ; Thomas GA; ; Aldred MA; Shovlin CL
    Am J Med Genet A; 2022 Mar; 188(3):959-964. PubMed ID: 34904380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulmonary arteriovenous malformations may be the only clinical criterion present in genetically confirmed hereditary haemorrhagic telangiectasia.
    Anderson E; Sharma L; Alsafi A; Shovlin CL
    Thorax; 2022 Jun; 77(6):628-630. PubMed ID: 35165143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-invasive CT screening for pulmonary arteriovenous malformations in children with confirmed hereditary hemorrhagic telangiectasia: Results from two pediatric centers.
    Soysal N; Eyries M; Verlhac S; Escabasse V; Remus N; Tamalet A; Rioux JY; Franchi-Abella S; Vasile M; Robert S; Delestrain C; Hau I; Ducou-Le Pointe H; Soubrier F; Carette MF; Epaud R
    Pediatr Pulmonol; 2017 May; 52(5):642-649. PubMed ID: 28165669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutational and clinical spectrum of Japanese patients with hereditary hemorrhagic telangiectasia.
    Kitayama K; Ishiguro T; Komiyama M; Morisaki T; Morisaki H; Minase G; Hamanaka K; Miyatake S; Matsumoto N; Kato M; Takahashi T; Yorifuji T
    BMC Med Genomics; 2021 Dec; 14(1):288. PubMed ID: 34872578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulmonary vascular manifestations of hereditary hemorrhagic telangiectasia (rendu-osler disease).
    Cottin V; Dupuis-Girod S; Lesca G; Cordier JF
    Respiration; 2007; 74(4):361-78. PubMed ID: 17641482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The clinical and genetic features of hereditary haemorrhagic telangiectasia (HHT) in central South Africa-three novel pathogenic variants.
    Mutize TT; Seedat RY; Ploos van Amstel JK; Mager JJ; Brown SC; Gebremariam F; Coetzee MJ
    Mol Biol Rep; 2020 Dec; 47(12):9967-9972. PubMed ID: 33201366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current HHT genetic overview in Spain and its phenotypic correlation: data from RiHHTa registry.
    Sánchez-Martínez R; Iriarte A; Mora-Luján JM; Patier JL; López-Wolf D; Ojeda A; Torralba MA; Juyol MC; Gil R; Añón S; Salazar-Mendiguchía J; Riera-Mestre A;
    Orphanet J Rare Dis; 2020 Jun; 15(1):138. PubMed ID: 32503579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel mutations in ENG and ACVRL1 identified in a series of 200 individuals undergoing clinical genetic testing for hereditary hemorrhagic telangiectasia (HHT): correlation of genotype with phenotype.
    Bossler AD; Richards J; George C; Godmilow L; Ganguly A
    Hum Mutat; 2006 Jul; 27(7):667-75. PubMed ID: 16752392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutation analysis of "Endoglin" and "Activin receptor-like kinase" genes in German patients with hereditary hemorrhagic telangiectasia and the value of rapid genotyping using an allele-specific PCR-technique.
    Sadick H; Hage J; Goessler U; Stern-Straeter J; Riedel F; Hoermann K; Bugert P
    BMC Med Genet; 2009 Jun; 10():53. PubMed ID: 19508727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulmonary arterio-venous malformations in a patient with a novel mutation in exon 10 of the ACVRL1 gene.
    Vandenbriele C; Peerlinck K; de Ravel T; Verhamme P; Vanassche T
    Acta Clin Belg; 2014 Apr; 69(2):139-41. PubMed ID: 24724759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.